SuperworthEdgewise Therapeutics shares outstanding EWTX
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 107.7M
- On a year earlier
- +2.6%
- more shares
Edgewise Therapeutics had 107.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 106M | +12% |
| FY2024 | 94.7M | +46% |
| FY2023 | 64.8M | +2% |
| FY2022 | 63.2M | +28% |
| FY2021 | 49.4M | +4797% |
| FY2020 | 1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 107.7M | +3% | |
| Q1 FY26 | 107.1M | +13% | |
| Q4 FY25 | 106M | +12% | |
| Q3 FY25 | 105.5M | +12% | |
| Q2 FY25 | 104.9M | +12% | |
| Q1 FY25 | 95.1M | +9% | |
| Q4 FY24 | 94.7M | +46% | |
| Q3 FY24 | 93.8M | +48% | |
| Q2 FY24 | 93.5M | +48% | |
| Q1 FY24 | 87.6M | +38% | |
| Q4 FY23 | 64.8M | +2% | |
| Q3 FY23 | 63.5M | +22% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Edgewise Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.